Should preserving contract pharmacy arrangements be a policy priority when the evidence shows that many of these arrangements benefit large pharmacy chains and intermediaries as much—or more—than the patients Congress ultimately intended to help with 340B has created over 30 years ago?
Related Posts
Medicaid and Children’s Health: 5 Issues to Watch Amid Recent Federal Changes
The uninsured rate, supplemental poverty rate, and food insecurity for children have all increased since the expiration of pandemic-era fiscal relief, and high household costs, […]
How Trump Aims To Slash Federal Support for Research, Public Health, and Medicaid
Health care has proved a vulnerable target for the firehose of cuts and policy changes President Donald Trump ordered in the name of reducing waste […]
Robert Krayn & Georgia Caveras, Talkiatry – The Health Care Blog
Health Tech Jan 9, 2025 Robert Krayn is the CEO and & Dr. Georgia Caveras the CMO of Talkiatry. Robert and Georgia are quite the […]